Author:
Niehues Tim,Wagner Norbert,Schütz Catharina,von Bismarck Philipp
Publisher
Springer Berlin Heidelberg
Reference89 articles.
1. Akhavan PS, Su J, Lou W, Gladman DD, Urowitz MB, Fortin PR (2013) The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus. J Rheumatol 40(6):831–841
2. Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS Jr, Rocha FA (2014) A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis. J Rheumatol 41(2):338–344
3. Appel GB, Contreras G, Dooley MA et al (2009) Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis. J Am Soc Nephrol 20:1103–1112
4. Aragon E, Chan YH, Ng KH et al (2010) Good outcomes with mycophenolate-cycclosporine-based induction protocol in children with severe proliferative lupus nephritis. Lupus 9:965–973
5. Attanasi M, Lucantoni M, Rapino D, Petrosino MI, Marsili M, Gasparroni G et al (2019) Lung function in children with juvenile idiopathic arthritis: a cross-sectional analysis. Pediatr Pulmonol 54(8):1242–1249